NeueHealth to Host Fourth Quarter 2024 Earnings Conference Call on March 20, 2025

NeueHealth, Inc. (NEUE), a value-driven healthcare company, has announced that it will host its fourth quarter 2024 earnings conference call on March 20, 2025. The call, which will be held at 8:00 a.m. Eastern Time, will provide investors with an opportunity to hear about the company's financial performance and strategic outlook for the coming year.



NeueHealth has been on a strong financial trajectory in 2024, driven by its focus on delivering coordinated, consumer-centric care to all populations across the ACA Marketplace, Medicare, and Medicaid. The company has reported positive Adjusted EBITDA for three consecutive quarters, reaffirming its guidance for the full year. In the third quarter of 2024, NeueHealth delivered its strongest financial performance to date, with revenue of $232.9 million and Adjusted EBITDA of $9.4 million.

The company's strong performance can be attributed to several key drivers, including:

1. Positive Adjusted EBITDA for three consecutive quarters: This indicates that NeueHealth has been consistently generating profits, demonstrating the effectiveness of its cost management and revenue growth strategies.
2. Strong financial performance in Q3 '24: NeueHealth's strongest financial performance to date in Q3 '24 was driven by continued positive momentum in both its NeueCare and NeueSolutions business segments, highlighting the company's diversified business model.
3. Reaffirming Adjusted EBITDA guidance for the full year: Despite the strong Q3 results, NeueHealth reaffirmed its guidance for the full year, indicating that the company is maintaining a realistic and conservative outlook on its financial performance.
4. Well-positioned for strategic growth opportunities: NeueHealth's strong performance in Q3 '24, combined with its reaffirmed guidance for the full year, suggests that the company is well-positioned to capitalize on strategic growth opportunities in 2025 and beyond.



Investors will be eager to hear more about NeueHealth's plans for 2025, including its growth strategies, potential acquisitions, and any updates on its financial guidance. The company's focus on value-driven, consumer-centric care has positioned it well within the competitive healthcare landscape, and its strong financial performance in 2024 suggests that it is well-equipped to continue its growth trajectory in the coming year.

As NeueHealth prepares to host its fourth quarter 2024 earnings conference call, investors will be looking for insights into the company's plans for the coming year. With its strong financial performance in 2024 and its well-positioned strategy, NeueHealth is poised for continued growth and success in 2025 and beyond.